Vorontsova Maria

Russian Young Endocrinologists Society co-chair

E-mail: maria.v.vorontsova@mail.ru


2005 – 2011: Moscow State University, Faculty of basic medicine
2011 – 2014: Resident at the Institute for Paediatric Endocrinology, Endocrinology Research Centre
2014 – present time: PhD student in the Institute for Paediatric Endocrinology, Endocrinology Research Centre

Professional experience

Resident and PhD student at the Institute for Paediatric Endocrinology, Endocrinology Research Centre
Research projects
Basic research:
1. Biophysics: “Free radicals and apoptosis: cardiolipin specifically activates peroxidase activity of cytochrome C.”
2. Pathophysiology/Pharmacology: “Chronic administration of serotonin transporter inhibitor (fluoxetine) renders dual effect on the development of monocrotaline-induced pulmonary hypertension in rats.”
3. Adipokine visfatin in blood serum of children and visfatin (PBEF-1) gene expression in adipose tissue in children.
4. Growth and metabolic effects of recombinant growth hormone therapy in children with idiopathic short stature [1] 5. Current project: Treatment of growth hormone deficient children with recombinant growth hormone: clinical and economical aspects [2-6] Clinical work experience: 4 years

Membership in scientific societies

Russian endocrinologists association, Russian young endocrinologists society (RYES), European society for paediatric endocrinology (ESPE), European society for endocrinology (ESE), European young endocrinologists society (EYES), Deutsche Gesellschaft für Endokrinologie (DGE), Endo Society

Main research interests

Growth hormone and growth disorders in children, disorders of sex development, disorders of the adrenal gland

Additional information 

Languages: English, German, French, Dutch

  • Vorontsova MV, Pankratova MS. Molecular genetic investigations of the cases of idiopathic short stature. PE. 2012;58(1):45-53. doi: 10.14341/probl201258145-53
  • Pankratova MS, Iusipovich AI, Vorontsova MV, Kovalenko SS, Baĭzhumanov AA, Parshina EI, et al. Peculiarities of the blood oxygen and antioxidant status in the children presenting with somatotrophic insufficiency and managed by the substitution treatment with growth hormone. PE. 2012;58(5):10-5. doi: 10.14341/probl201258510-15
  • Pankratova MS, Yusipovich AI, Vorontsova MV, Knyazeva TT, Baizhumanov AA, Shiryaeva TY, et al. Effect of oxidative stress on major plasma carotenoid content and composition in prepubertal children with growth hormone deficiency. PE. 2017;62(6):4-9. doi: 10.14341/probl20166264-9
  • Vorontsova MV. Economic and social aspects of growth hormone therapy in children and adults with growth hormone deficiency. Literature review. PE. 2016;62(2):61-8. doi: 10.14341/probl201662261-68
  • Vorontsova MV. Incidence and prevalence of growth hormone deficiency in the russian federation according to the official medical statistics data and the growth hormone deficiency patients registry. PE. 2016;62(4):18-26. doi: 10.14341/probl201662418-26

Leave a Reply